¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"alpha chain disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • Canavan disease
    ij³Ê¹øº´
  • cholesteryl ester storage disease
    ÄÝ·¹½ºÅ×·Ñ¿¡½ºÅ׸£ÃàÀûº´
  • chronic granulomatous disease
    ¸¸¼ºÀ°¾ÆÁ¾º´
  • chronic obstructive pulmonary disease
    ¸¸¼ºÆó¼âÆóÁúȯ
  • deficiency disease
    °áÇ̺´
  • degenerative disease
    ÅðÇິ, º¯¼ºº´
  • degenerative joint disease
    ÅðÇà°üÀýº´
  • demyelinating disease
    ¸»ÀÌÁýÅ»¶ôº´, Å»¼öÃʺ´
  • dense deposit disease
    °í¹ÐµµÄ§Âøº´
  • depression spectrum disease
    ¿ì¿ï½ºÆåÆ®·³º´
  • de Quervain¡¯s disease
    µåÄù¸£¹ðº´
  • diarrheal disease
    ¼³»çº´
  • diffuse Lewy body disease
    ±¤¹üÀ§·¹ºñ¼Òüº´
  • digestive tract disease
    ¼ÒÈ­°üº´
  • disease
    º´, Áúº´, Áúȯ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • diffuse collagen disease
    ±¤¹üÀ§¾Æ±³Áúº´, ¹Ì¸¸¾Æ±³Áúº´
  • diffuse interstitial pulmonary disease
    ±¤¹üÀ§»çÀÌÁúÆóº´, ¹Ì¸¸°£ÁúÆóº´
  • digestive tract disease
    ¼ÒÈ­°üº´
  • disease detection
    Áúº´¹ß°ß
  • disease entity
    Áúº´´ÜÀ§, Áúº´¸í
  • disease potential
    Áúº´ÀáÀç·Â
  • disease registry
    Áúº´µî·Ïü°è
  • disease susceptibility
    Áúº´°¨¼ö¼º
  • disease taxonomy
    Áúº´ºÐ·ùÇÐ
  • disease vector
    Áúº´¸Å°³Ã¼
  • disease free survival
    ¹«º´»ýÁ¸
  • disease frequency survey
    Áúº´ºóµµÁ¶»ç
  • disease odds ratio
    Áúº´±³Â÷ºñ
  • dust disease
    ¸ÕÁöº´
  • endemic disease
    dzÅ亴
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • Corvisart s disease
    ÄÚ¸£ºñÀÚ¸£º´.
  • Coutons disease
    ÄíÅ뺴.
  • Creutzfeld-Jakob disease
    Å©·ÎÀÌÃ÷ÆçÆ®-¾ßÄߺ´.
  • Creutzfeld-Jakob disease
    Å©·ÎÀÌÃ÷ÆçÆ®-¾ßÄߺ´.
  • Creutzfeldt-Jakob disease
    Å©·ÎÀÌÃ÷ÆçÆ®-¾ßÄß º´
  • Creutzfeldt-Jakob disease(CJD)
    Å©·ÎÀÌÃ÷ÆçÆ®¾ßÄߺ´
  • Crohns disease
    Å©·Ðº´
  • Crohns disease
    Å©·Ðº´.
  • Crouzons disease =craniofacial dysostosis
    µÎ°³¾È¸éȸ°ñºÎÀüÁõ, Å©·ç Á¾º´ µÎ°³¾È¸éÀ̰ñÁõ .
  • Cushings disease
    Äí½Ìº´.
  • Dariers disease => keratosis follicularis
    ´Ù¸®¿¡ º´
  • Degenerative disease
    ÅðÇ༺Áúȯ
  • Dego s disease
    µ¥°íº´.
  • Dejerine-Sottas disease
    µ¥Á¦¸°-¼ÚŸº´.
  • Dercums disease
    ´õÄĺ´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • light-chain nephropathy
    °æ¼â ½ÅÁõ(Ìã ãìñø)
  • mu (¥ì) chain
    ¹Â»ç½½, ¹Â¼â
  • multiple chain
    º¹½Ä(ÜÜãÒ)»ç½½.
  • nuclear chain
    Çٻ罽, ÇÙ¼â(ú·áð).
  • nuclear chain fiber
    Çٻ罽±ÙÀ°¼¼Æ÷
  • open chain compound
    ¿­¸°»ç½½È­ÇÕ¹° °³¼âÈ­ÇÕ¹°(ËÒáðûùùêÚª) .
  • open chain form
    ¿­¸°»ç½½Çü.
  • ossicular chain
    À̼Ұñ¿¬¼â, °í½ÇÀÛÀº»À°í¸®{ÇØ}
  • ossicular chain reconstruction
    À̼Ұñ¿¬¼âÀç°Ç
  • oxidative chain
    »êÈ­¿¬¼â.
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ
  • polymerase chain reaction
    Á¾ÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • polymerase chain reaction (PCR)
    ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ
  • polymerase chain reaction(PCR)
    ÁßÇÕ ¿¬¼â ¹ÝÀÀ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • very long-chain fatty acids
    ¸Å¿ì ±ä »ç½½ Áö¹æ»ê(ò·Û¸ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
GBD gallbladder disease; gender behavior disorder; glass blower's disease; granulomatous bowel disease
GD gastroduodenal; Gaucher disease; general diagnostics; general dispensary; gestational day; Gianotti ...
ICD I-cell disease; immune complex disease; implantable cardioverter defibrillator; impulse-control diso...
ID identification; iditol dehydrogenase; immunodeficiency; immunodiffusion; immunoglobulin deficiency; ...
ILD interstitial lung disease; intraoperative localization device; ischemic leg disease; ischemic limb d...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
alpha 1-m Alpha 1-Microglobulin
alpha 1-AG Alpha 1-acid glycoprotein
alpha 1-AGP Alpha 1-acid glycoprotein
alpha 1-ACT Alpha 1-antichymotrypsin
alpha 1Pi Alpha 1-protease inhibitor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cytomegaloviral disease
    °Å´ë ¼¼Æ÷ ¹ÙÀÌ·¯½º Áúȯ
  • Darier's disease
    ´ë¸®¾î º´
    µ¿ÀǾî=
  • degenerative brain disease
    ÅðÇ༺ ³ú Áúȯ
  • degenerative disease
    ÅðÇ༺ Áúȯ
  • degenerative joint disease
    ÅðÇ༺ °üÀý Áúȯ
    °üÀý ±¸Á¶¹°¿¡ ÀûÀÀ ÇѰ踦 ³Ñ¾î¼­´Â ÈûÀÌ °è¼Ó °¡ÇØÁö¸é °üÀý¸é, Ȱ¸·, °üÀý³¶¿¡ ¿°Áõ¼º º´º¯ÀÌ »ý±â´Â °æ¿ì.
  • demyelination disease
    Å»¼öÃÊ Áúȯ
    ½Å°æ¿¡ ¼öÃʰ¡ ¾ø¾î¼­ µµ¾à Àüµµ°¡ ÀϾÁö ¾Ê¾Æ ¾ß±âµÇ´Â Áúȯµé.
  • dercums disease
    ´õÄÄ º´
  • devics disease
    µ¥ºò º´
    µ¿ÀǾî=o
  • digestive tract disease
    ¼ÒÈ­±â °èÅë Áúȯ
  • disease
    º´, Áúº´, Áúȯ
    ÀÎÁö °¡´ÉÇÑ ÀÏ·ÃÀÇ Â¡ÈÄ¿Í Áõ»ó, ½Åü ¼Ò°ßÀÌ Æ¯Â¡ÀÎ Áúº´
  • disease entity
    Áúº´ ´ÜÀ§
  • disease of the esophagus
    ½Äµµ Áúȯ
  • disease of the lymphreticular system
    ¸²ÇÁ ¼¼¸Á³»ÇǰèÀÇ Áúȯ
  • disease of the pancreas
    ÃéÀå Áúȯ
  • double vessel disease
    ÀÌÁß °ü»ó µ¿¸Æ Áúȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
alpha alcoholism Jellinek's term for a still controllable and strictly psychological dependence on alcohol, as to relieve emotional or physical pain, with resulting interference with interpersonal relationships.
(05 Mar 2000)
alpha-allocortol 5alpha-Pregnane-3a,11b,17,20a,21-pentaol;the 5a enantiomer of alpha-cortol; a metabolite of hydroxycortisone found in the urine.
(05 Mar 2000)
alpha-allocortolone 3a,17,20a,21-Tetrahydroxy-5alpha-pregnane-11-one;the 5a enantiomer of alpha-cortolone; a metabolite of hydrocortisone found in urine.
(05 Mar 2000)
alpha-allopregnanediol 5alpha-Pregnane-3a,20alpha-diol;a metabolite of progesterone and adrenocortical hormones, found in urine.
(05 Mar 2000)
alpha-amanitin <drug> A highly toxic, heat-stable bicyclic oligopeptide derived from the Amanita phalloides mushroom. It inhibits transcription by interfering with the function of certain RNA polymerases.
(14 Aug 2000)
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid <chemical> Alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid. An ibotenic acid homolog and glutamate agonist. The compound is the defining agonist for the ampa subtype of glutamate receptors (receptors, ampa). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.
Pharmacological action: excitatory amino acid agonists.
Chemical name: 4-Isoxazolepropanoic acid, alpha-amino-2,3-dihydro-5-methyl-3-oxo-
(12 Dec 1998)
alpha-amino acid Typically, an amino acid of the general formula R-CHNH2-COOH (i.e., the NH2 in the a position); the l forms of these are the hydrolysis products of proteins. In rarer usages, this class of molecules also includes alpha-amino phosphoric acids and alpha-aminosulfonic acids.
(05 Mar 2000)
alpha-amino acid esterase <enzyme> Converts alpha-amino acid esters and water to alpha-amino acids and alcohol
Registry number: EC 3.1.1.43
Synonym: alpha-amino acid ester hydrolase
(26 Jun 1999)
alpha-aminoacyl-peptide hydrolases <enzyme> Registry number: EC 3.4.11.
(12 Dec 1998)
alpha-aminoadipic acid 2-amino-1,6-hexanedioic acid;an intermediate of lysine biosynthesis in higher fungi and bacteria, but not in algae and higher plants. Also in degradation of lysine in mammals.
(05 Mar 2000)
alpha-aminoadipyl-cysteinyl-valine synthetase <enzyme> As of 9/27/95 this has been separated from isopenicillin n synthetase
Registry number: EC 6.3.2.-
Synonym: acv synthetase, aa-cysteine synthetase, delta-(alpha-aminoadipyl)-cys-val synthetase, delta-(l-alpha-aminoadipyl)-l-cyteinyl-d-valine synthetase, pcbab gene product, acva gene product
(26 Jun 1999)
alpha-amino-beta-ketoadipic acid 2-Amino-3-oxo-1,6-hexanedioic acid;an intermediate of porphobilinogen synthesis formed by d-aminolevulinic acid synthase from succinyl-CoA and glycine; it rapidly decarboxylates to d-aminolevulinic acid.
(05 Mar 2000)
alpha-aminoglutaric acid <amino acid> One of the 20 _ amino acids commonly found in proteins. Plays a central role in amino acid metabolism, acting as precursor of glutamine, proline and arginine. Also acts as amino group donor in synthesis by transamination of alanine from pyruvate and aspartic acid from oxaloacetate. Glutamate is also a neurotransmitter, the product of its decarboxylation is the inhibitory neurotransmitter amino butyrate (GABA).
(18 Nov 1997)
alpha-aminoisobutyric acid 2-amino-2-methylpropionic acid;a synthetic amino acid useful in the study of amino acid transport across cell membranes and in the study of cytokine effects; it is not metabolised by the cell.
(05 Mar 2000)
alpha-aminosuccinic acid <amino acid> One of the twenty naturally occurring amino acids. Has the following chemical characteristics: pKa1 pKa2 pKa3 pI Water Solubility (30deg C)2.09-3.86 9.82 2.97 0.6
(09 Oct 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
ÅëÇÕ°Ë»ö ¿Ï·á